Systemic treatments of the vasospasm;Traitements systémiques du vasospasme

Annales Francaises d'Anesthesie et de Reanimation

Volumn 26, Issue 11, 2007, Pages 980-984

  Tavernier, B ^a   Decamps, F ^a   Vega, E ^a   Poidevin, P ^a   Verdin, M ^a   Riegel, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Subarachnoid haemorrhage; Vasospasm

Indexed keywords

CLAZOSENTAN; DOBUTAMINE; ENDOTHELIN A RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; MAGNESIUM; MAGNESIUM SULFATE; NICARDIPINE; NIMODIPINE; PLACEBO; PRAVASTATIN; SIMVASTATIN; TIRILAZAD;

ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DEPLETION; DRUG SAFETY; HEART OUTPUT; HEMODILUTION; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERVOLEMIA; NEUROPROTECTION; NONHUMAN; RISK BENEFIT ANALYSIS; SUBARACHNOID HEMORRHAGE; SYSTEMIC THERAPY;

EID: 36348934710     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2007.08.012     Document Type: Article

References (32)

1. Sfar, Association de neuroanesthésie de langue française, Société française de neurochirurgie, Société française de neuroradiologie. Conférence d'experts. Hémorragie sous-arachnoïdienne grave (texte court). 2004. http://www.sfar.org/s/IMG/pdf/hgiesousarach_cexp.pdf.
2. Berré J., Gabrillargues J., Audibert G., Hans P., Bonafé A., Boulard G., et al. Hémorragies méningées graves : prévention, diagnostic et traitement du vasospasme. Ann. Fr. Anesth. Reanim. 24 (2005) 761-774
3. Sen J., Belli A., Albon H., Morgan L., Petzold A., and Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2 (2003) 614-621
4. Suarez J.I., Tarr R.W., and Selman W.R. Aneurysmal subarachnoid hemorrhage. N. Engl. J. Med. 354 (2006) 387-396
5. Brisman J.L., Song J.K., and Newell D.W. Cerebral Aneurysms. N. Engl. J. Med. 355 (2006) 928-939
6. Feigin V.L., and Findlay M. Advances in subarachnoid hemorrhage. Stroke 37 (2006) 305-308
7. McDonald R.L. Management of cerebral vasospasm. Neurosurg. Rev. 29 (2006) 179-193
8. Treggiari M.M., Walder B., Suter P.M., and Romand J.A. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J. Neurosurg. 98 (2003) 978-984
9. Rinkel G.J.E., Feigin V.L., Algra A., and van Gijn J. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. 18 (2004) CD000483
10. Lennihan L., Mayer S.A., Fink M.E., Beckford A., Paik M.C., Zhang H., et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31 (2000) 383-391
11. Naval N.S., Stevens R.D., Mirski M.A., and Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit. Care Med. 34 (2006) 511-524
12. Hoh B.L., Carter B.S., and Ogilvy C.S. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy. Neurosurgery 50 (2002) 1207-1211
13. Keller T.S., McGillicuddy J.E., LaBond V.A., and Kindt G.W. Modification of focal cerebral ischemia by cardiac output augmentation. J. Surg. Res. 39 (1985) 420-432
14. Tone O., Tomita H., Tamaki M., Hara M., and Inaji M. Correlation between cardiac output and cerebral blood flow following subarachnoid hemorrhage. Keio J. Med. 49 Suppl 1 (2000) A151-A153
15. Kim D.H., Joseph M., Ziadi S., Nates J., Dannenbaum M., and Malkoff M. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 53 (2003) 1044-1052
16. Levy M.L., Rabb C.H., Zelman V., and Giannotta S.L. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J. Neurosurg. 79 (1993) 494-499
17. Nussbaum E.S., Sebring L.A., Ganz W.F., and Madison M.T. Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study. Neurosurgery 42 (1998) 206-213
18. Rosen C.L., Sekhar L.N., and Duong D.H. Use of intra-aortic balloon pump counterpulsation for refractory symptomatic vasospasm. Acta Neurochir. (Wien) 142 (2000) 25-32
19. Lylyk P., Vila J.F., Miranda C., Ferrario A., Romero R., and Cohen J.E. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol. Res. 27 (2005) S129-SS35
20. Rinkel G.J., Feigin V.L., Algra A., van den Bergh W.M., Vermeulen M., and van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. 25 (2005) CD000277
21. Ohkuma H., Manabe H., Tanaka M., and Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31 (2000) 1621-1627
22. Van den Bergh W.M., Algra A., Van Kooten F., Dirven C.M., Van Gijn J., Vermeulen M., et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36 (2005) 1011-1015
23. Wong G.K.C., Chan M.T.V., Boet R., Poon W.S., and Gin T. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J. Neurosurg. Anesthesiol. 18 (2006) 142-148
24. Wanebo J.E., Arthur A.S., Louis H.G., West K., Kassell N.F., Lee K.S., et al. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery 43 (1998) 1409-1417
25. Vajkoczy P., Meyer B., Weidauer S., Raabe A., Thome C., Ringel F., et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J. Neurosurg. 103 (2005) 9-17
26. Parra A., Kreiter K.T., Williams S., Sciacca R., Mack W.J., Naidech A.M., et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56 (2005) 476-484
27. Singhal A.B., Topcuoglu M.A., Dorer D.J., Ogilvy C.S., Carter B.S., and Koroshetz W.J. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64 (2005) 1008-1013
28. Gertz K., Laufs U., Lindauer U., Nickenig G., Böhm M., Dirnagl U., et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34 (2003) 551-557
29. McGirt M.J., Lynch J.R., Parra A., Sheng H., Pearlstein R.D., Laskowitz D.T., et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33 (2002) 2950-2956
30. McGirt M.J., Pradilla G., Legnani F.G., Thai Q.A., Recinos P.F., Tamargo R.J., et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58 (2006) 945-951
31. Lynch J.R., Wang H., McGirt M.J., Floyd J., Friedman A.H., Coon A.L., et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 36 (2005) 2024-2026
32. Tseng M.Y., Czosnyka M., Richards H., Pickard J.D., and Kirkpatrick P.J. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36 (2005) 1627-1632